The online version of this article (doi:10.1007/s13300-017-0272-5) contains supplementary material, which is available to authorized users.
Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/4598F0606F7F5B58.
The role of mobile technology in patient-reported outcomes (PRO) and glycemic control in adults with type 1 diabetes (T1D) needs further evaluation.
The single-center, prospective, 6-month, open-label, investigator-initiated study randomized 100 subjects with T1D in a 1:1 fashion to a control group using self-monitoring of blood glucose (SMBG) with Accu-Chek Nano® and an intervention group using SMBG with iPhone plus glucose meter (iBGStar®). The primary endpoint was the change in PRO (hypoglycemia fear score, behavior and worry subscores). Secondary outcomes were the improvement in glycemic variability indices and the reduction in A1c values.
Baseline demographics and glycosylated hemoglobin (A1c) values were similar in the two groups. There was a significant decrease in A1c value at 6 months in iBGStar® group compared to the control group (−0.16 vs. −0.51, p = 0.04). The total insulin dose increased significantly in the iBGStar® group at 3 months but did not change at 6 months. The hypoglycemia fear scale (PRO) improved in both groups at 6 months (−1.4 ± 10.0 vs. −3.9 ± 12.5, p = 0.32).
The use of iBGStar® resulted in better glycemic control and improvement in some PRO (hypoglycemia fear and behavior scores) compared to the control group at 6 months with no increased risk of hypoglycemia.
Supplementary material 1 (DOCX 15 kb)13300_2017_272_MOESM1_ESM.docx
Garg S, Hirsch IB. Self-monitoring of blood glucose. Int J Clin Pract Suppl. 2010;166:1–10. CrossRef
American Diabetes Association. Standards of medical care in diabetes-2015. Diabetes Care. 2015;38:S1–90.
Spollet GR. Self-monitoring of blood glucose: an underutilized tool. Clin Diabetes. 2010;28:127–9. CrossRef
Kirwan M, Vandelanotte C, Fenning A, Duncan MJ. Diabetes self-management smartphone application for adults with type 1 diabetes: randomized controlled trial. J Med Int Res. 2013;15(11):e235.
- Role of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study iBGStar® in Type 1 Diabetes Management
Satish K. Garg
Viral N. Shah
Halis K. Akturk
Janet K. Snell-Bergeon
- Springer Healthcare
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II